155 related articles for article (PubMed ID: 9065641)
1. Positive impact of retinyl palmitate in leukoplakia of the larynx.
Issing WJ; Struck R; Naumann A
Eur Arch Otorhinolaryngol; 1997; 254 Suppl 1():S105-9. PubMed ID: 9065641
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up of larynx leukoplakia under treatment with retinyl palmitate.
Issing WJ; Struck R; Naumann A
Head Neck; 1996; 18(6):560-5. PubMed ID: 8902570
[TBL] [Abstract][Full Text] [Related]
3. [High concentrate A-mulsin, a new therapy concept in laryngeal leukoplakia].
Issing WJ; Struck R; Naumann A; Kastenbauer E
Laryngorhinootologie; 1996 Jan; 75(1):29-33. PubMed ID: 8851116
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy and the treatment of neoplastic diseases of the larynx.
Biel MA
Laryngoscope; 1994 Apr; 104(4):399-403. PubMed ID: 8164476
[TBL] [Abstract][Full Text] [Related]
5. Randomized trial of 13-cis retinoic acid compared with retinyl palmitate with or without beta-carotene in oral premalignancy.
Papadimitrakopoulou VA; Lee JJ; William WN; Martin JW; Thomas M; Kim ES; Khuri FR; Shin DM; Feng L; Hong WK; Lippman SM
J Clin Oncol; 2009 Feb; 27(4):599-604. PubMed ID: 19075276
[TBL] [Abstract][Full Text] [Related]
6. The role of narrow-band imaging (NBI) endoscopy in optical biopsy of vocal cord leukoplakia.
Staníková L; Šatanková J; Kučová H; Walderová R; Zeleník K; Komínek P
Eur Arch Otorhinolaryngol; 2017 Jan; 274(1):355-359. PubMed ID: 27515705
[TBL] [Abstract][Full Text] [Related]
7. Initial experience in the treatment of oral leukoplakia with high-dose vitamin A and follow-up 5-aminolevulinic acid induced protoporphyrin IX fluorescence.
Leunig A; Betz CS; Baumgartner R; Grevers G; Issing WJ
Eur Arch Otorhinolaryngol; 2000; 257(6):327-31. PubMed ID: 10993553
[TBL] [Abstract][Full Text] [Related]
8. EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the EUropean Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups.
van Zandwijk N; Dalesio O; Pastorino U; de Vries N; van Tinteren H
J Natl Cancer Inst; 2000 Jun; 92(12):977-86. PubMed ID: 10861309
[TBL] [Abstract][Full Text] [Related]
9. [Clinical analyses of 263 patients with laryngeal leukoplakia].
Niu YY; Wang J; Huo H; Jin XF; Li WY; Gao ZQ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Aug; 53(8):575-580. PubMed ID: 30121994
[No Abstract] [Full Text] [Related]
10. Pilot phase IIA study for evaluation of the efficacy of folic acid in the treatment of laryngeal leucoplakia.
Almadori G; Bussu F; Navarra P; Galli J; Paludetti G; Giardina B; Maurizi M
Cancer; 2006 Jul; 107(2):328-36. PubMed ID: 16770770
[TBL] [Abstract][Full Text] [Related]
11. Positive therapy of andrographolide in vocal fold leukoplakia.
Xu J; Xue T; Bao Y; Wang DH; Ma BL; Yin CY; Yang GH; Ren G; Lan LJ; Wang JQ; Zhang XL; Zhao YQ
Am J Otolaryngol; 2014; 35(2):77-84. PubMed ID: 24444776
[TBL] [Abstract][Full Text] [Related]
12. Dysplastic Changes in Patients with Recurrent Laryngeal Leukoplakia: Importance of Long-Term Follow-Up.
Jabarin B; Pitaro J; Marom T; Muallem-Kalmovich L
Isr Med Assoc J; 2018 Oct; 20(10):623-626. PubMed ID: 30324779
[TBL] [Abstract][Full Text] [Related]
13. Circulating endogenous retinoic acid concentrations among participants enrolled in a randomized placebo-controlled clinical trial of retinyl palmitate.
Sedjo RL; Ranger-Moore J; Foote J; Craft NE; Alberts DS; Xu MJ; Giuliano AR
Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1687-92. PubMed ID: 15533894
[TBL] [Abstract][Full Text] [Related]
14. The impact of laryngeal dysplasia on the development of laryngeal squamous cell carcinoma.
Luers JC; Sircar K; Drebber U; Beutner D
Eur Arch Otorhinolaryngol; 2014 Mar; 271(3):539-45. PubMed ID: 23990060
[TBL] [Abstract][Full Text] [Related]
15. Morphometric analysis of Ki-67 and p16 expression in laryngeal precursor lesions.
Pavlovic B; Djukic V; Milovanovic J; Tomanovic N; Milovanovic A; Trivic A
Eur Arch Otorhinolaryngol; 2013 Mar; 270(4):1405-10. PubMed ID: 23408022
[TBL] [Abstract][Full Text] [Related]
16. [Analyses of pathogenic factors and clinicopathological characteristics of vocal leukoplakia].
Wang WL; Zhang LH; Cao J; Li CF; Wang YG; Zhao YX
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Aug; 53(8):581-586. PubMed ID: 30121995
[No Abstract] [Full Text] [Related]
17. Chemoprevention of oral leukoplakia with vitamin A and beta carotene: an assessment.
Sankaranarayanan R; Mathew B; Varghese C; Sudhakaran PR; Menon V; Jayadeep A; Nair MK; Mathews C; Mahalingam TR; Balaram P; Nair PP
Oral Oncol; 1997 Jul; 33(4):231-6. PubMed ID: 9307711
[TBL] [Abstract][Full Text] [Related]
18. [The study of the evolution of laryngeal premalignant lesions].
Rodríguez García L; Landa Aranzábal MA; Rivas Salas A; Abrego Olano M; Algaba Guimera J
Acta Otorrinolaringol Esp; 1996; 47(2):129-33. PubMed ID: 8695202
[TBL] [Abstract][Full Text] [Related]
19. Inhalation of aerosolized vitamin a: reversibility of metaplasia and dysplasia of human respiratory epithelia -- a prospective pilot study.
Kohlhäufl M; Häussinger K; Stanzel F; Markus A; Tritschler J; Mühlhöfer A; Morresi-Hauf A; Golly I; Scheuch G; Jany BH; Biesalski HK
Eur J Med Res; 2002 Feb; 7(2):72-8. PubMed ID: 11891147
[TBL] [Abstract][Full Text] [Related]
20. Phonosurgical resection using submucosal infusion technique for precancerous laryngeal leukoplakia.
Kono T; Saito K; Yabe H; Ogawa K
Laryngoscope; 2017 Jan; 127(1):153-158. PubMed ID: 27107249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
